Oruka Therapeutics, Inc. (ORKA)

NGM – Цена в реальном времени. Валюта: USD

107.13

+2.45 (2.34%)

При закрытии: Aug 12, 2026, 3:59 PM EDT

105.26

-2.14 (-1.99%)

После закрытия: Aug 12, 2026, 6:02 PM EDT

11.08.2026

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.

10.08.2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

EVERLAST-A Week 28 data expected at the end of 3Q 2026; 52-week data for all participants expected in December 2026 EVERLAST-B fully enrolled ahead of schedule, with Week 16 data now expected in 4Q 2026 Phase 3 program for ORKA-001 expected to begin in 1H 2027 ORCA-SURGE Week 16 data accelerated, now expected in 1Q 2027 ORCA-SPLASH, a Phase 2 trial of ORKA-002 in moderate-to-severe hidradenitis suppurativa, initiated ORKA-004, a novel half-life extended monoclonal antibody targeting TL1A, to enter the clinic in 4Q 2026 Cash, cash equivalents and marketable securities of $1.1 billion expected to fund the Company through a BLA filing for ORKA-001

Видео

No Data

There is no data to display

Пресс-релизы

10.08.2026

Oruka Therapeutics, Inc. (ORKA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Oruka Therapeutics, Inc. (ORKA)

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

Oruka Therapeutics, Inc. (ORKA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Oruka Therapeutics, Inc. (ORKA)

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update